申请人:AURIGENE DISCOVERY TECHNOLOGIES LIMITED
公开号:US20180201609A1
公开(公告)日:2018-07-19
The present invention provides indazole and aza indazole compounds of formula (I) or (II) and pharmaceutically acceptable salts thereof, and their use to inhibit IRAK-4 and/or for the treatment of diseases or disorders induced by IRAK-4.